Clinical trial
A Prospective Randomised, Double-blinded Cross-over Study to Investigate the Effects of Racemic and S-ketamine on Cerebral Blood Flow on Healthy Volunteers With MRI-ASL
NCT01506921 is registered in ClinicalTrials.gov with Lund University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Randomised, Double-blinded Cross-over Study to Investigate the Effects of Racemic and S-ketamine on Cerebral Blood Flow on Healthy Volunteers With MRI-ASL
- Lead sponsor
- Lund University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 2011
- Completion date
- February 29, 2012
- Enrollment
- 14 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
abnormal vascular flow, healthy